← Back
Data updated: Mar 10, 2026
LEO PHARM
DermatologyImmunologyOncology
LEO PHARM is a pharmaceutical company focused on Dermatology, Immunology, Oncology. Key products include PICATO.
1989
Since
3
Drugs
-
Trials
2
Approved (2yr)
Key Drugs
No active drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 69%
0 drugs Phase 3: 17 Phase 2: 14 Phase 1: 11
Immunology 29%
0 drugs Phase 3: 6 Phase 2: 4 Phase 1: 13
Oncology 3%
0 drugs Phase 3: 1
Pipeline Strength Pro
Loading...